Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

SGMO Stock Annual Cash Flow. Download in Excel

Sangamo Therapeutics Inc. logo

Sangamo Therapeutics Inc.

Sector: Healthcare   

Industry: Biotechnology

2.47
 
USD
  
0.16
  
(6.93%)
Previous close: 2.31  Open: 2.3  Bid: 2.48  Ask: 2.5
52 week range    
0.30   
   3.18
Mkt Cap: 588 M  Avg Vol (90 Days): 8,033,642
Peers   
ALNY / 
GILD / 
AMGN / 
BIIB / 
BMRN / 
JNJ / 
DOW / 
Last updated: Sunday 22nd December 2024

Stock Rankings

51
MarketXLS Rank
40
Value
76
Technical
39
Quality
How are these ranks calculated?
Search for a stock

Financials

SGMO Cash Flow

Annual
Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
(Increase) Decrease in other current liabilities13 M-8 M-5 M49 M101 M-36 M217 M-84 M-91 M-161 M
(Increase) Decrease in other working capital4 M1 M1 M-9000.0-20000.0
(Increase) Decrease in payables4 M-764000.0-2 M3 M-6 M-4 M11 M-8 M13 M6 M
(Increase) Decrease in receivables-7 M8 M-2 M2 M-1 M-33 M31 M-103000.02 M3 M
Acquisitions-2 M-76 M-262000.0-704000.0-119000.0
Amortization of intangibles6 M8 M8 M8 M
AssetImpairmentCharge2 M155 M
CapitalExpenditureReported621000.02 M732000.04 M43 M21 M15 M23 M20 M21 M
Cash at beginning of period10 M6 M69 M22 M53 M144 M82 M133 M180 M102 M
Cash at end of period6 M69 M22 M53 M144 M82 M82 M133 M102 M47 M
Cash flow-6 M-32 M-66 M11 M37 M-144 M170 M-233 M-224 M-225 M
CashFlowFromContinuingInvestingActivities-100 M76 M18 M-77 M-178 M-60 M-272 M248 M59 M154 M
ChangeInAccountPayable4 M-764000.0-2 M3 M-6 M-4 M11 M-8 M13 M6 M
ChangeInPayablesAndAccruedExpense4 M-764000.0-2 M3 M-6 M-4 M11 M-8 M13 M6 M
ChangeInPrepaidAssets-258000.0376000.0-1 M-669000.0-3 M-7 M-10 M-7 M-5 M6 M
ChangeInWorkingCapital10 M-805000.0-11 M53 M91 M-75 M249 M-98 M-81 M-146 M
ChangesInAccountReceivables-7 M8 M-2 M2 M-1 M-32 M32 M-789000.02 M3 M
Current deferred income taxes-6 M-14000.0-6 M
Deferred income taxes-6 M-14000.0-6 M
Depreciation549000.0988000.0997000.01 M2 M4 M6 M9 M12 M15 M
Depreciation unreconciled2 M2 M1 M825000.0-3 M5 M13 M20 M19 M20 M
DepreciationAndAmortization2 M2 M1 M825000.0-3 M5 M13 M18 M21 M22 M
Effect of exchange rate changes439000.0184000.0-447000.0-263000.01 M1 M
FinancingCashFlow102 M20 M337000.097 M232 M142 M153 M33 M85 M15 M
Free cash flow-7 M-32 M-67 M7 M-7 M-165 M155 M-257 M-244 M-246 M
GainLossOnSaleOfPPE12000.068000.0222000.0-52000.0
Issuance of capital stock13 M7 M1 M17 M1 M2 M145 M
IssuanceOfCapitalStock13 M7 M1 M17 M1 M2 M145 M
Net cash from financing activities102 M20 M337000.097 M232 M142 M9 M2 M-2 M-1 M
Net cash from investing activities-100 M76 M18 M-77 M-178 M-60 M-272 M248 M59 M154 M
Net cash from operating activities-6 M-32 M-66 M11 M37 M-144 M170 M-233 M-224 M-225 M
Net change in cash & cash equivalents-4 M63 M-47 M31 M91 M-62 M51 M48 M-80 M-57 M
Net income from continuing operations-26 M-41 M-72 M-55 M-69 M-95 M-121 M-178 M-192 M-258 M
NetBusinessPurchaseAndSale-2 M-76 M-262000.0-704000.0-119000.0
NetCommonStockIssuance13 M7 M1 M17 M1 M2 M145 M
NetForeignCurrencyExchangeGainLoss602000.0
NetInvestmentPropertiesPurchaseAndSale-100 M78 M19 M-74 M-59 M-39 M-256 M272 M79 M175 M
NetInvestmentPurchaseAndSale-100 M78 M19 M-74 M-59 M-39 M-256 M272 M79 M175 M
NetPPEPurchaseAndSale-621000.0-2 M-732000.0-4 M-43 M-21 M-15 M-23 M-20 M-21 M
Operating (gains) losses-341000.0-105000.0137000.03 M3 M4 M7 M321000.0941000.0-13 M
Other financing charges net89 M13 M-776000.081 M216 M136 M-765000.0-3 M-2 M-1 M
Other investing changes net230000.0-2 M-3 M
Other non-cash items9 M14 M15 M9 M16 M17 M22 M22 M29 M178 M
PensionAndEmployeeBenefitExpense-341000.0-105000.0137000.03 M3 M4 M7 M373000.0941000.0-13 M
ProceedsFromStockOptionExercised15 M4 M9 M6 M124000.0
Purchase of Float term investments-444 M-571 M-338 M-277 M-60 M
Purchase of property plant & equipment-621000.0-2 M-732000.0-4 M-43 M-21 M-15 M-23 M-20 M-21 M
PurchaseOfInvestment-228 M-258 M-219 M-252 M-451 M-444 M-571 M-338 M-277 M-60 M
PurchaseOfLongTermInvestments-228 M-258 M-219 M-252 M-451 M
PurchaseOfPPE-621000.0-2 M-732000.0-4 M-43 M-21 M-15 M-23 M-20 M-21 M
Revenue per share1 M827000.0221000.0-673000.0-6 M969000.07 M11 M7 M5 M
Sale of Float term investments7 M357 M234 M
Sale of short term investments128 M338 M237 M179 M392 M405 M315 M603 M355 M
SaleOfInvestment128 M338 M237 M179 M392 M405 M315 M610 M357 M234 M
StockBasedCompensation9 M12 M15 M9 M15 M19 M26 M33 M32 M27 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University